The relevance of p53 mutation in urological malignancies: Possible clinical implications for bladder cancer

被引:15
作者
Nouri, AME
Darakhshan, F
Cannell, H
Paris, AMI
Oliver, RTD
机构
[1] ROYAL LONDON HOSP, DEPT ORAL MAXILLOFACIAL SURG, LONDON E1 1BB, ENGLAND
[2] ROYAL LONDON HOSP, DEPT UROL, LONDON E1 1BB, ENGLAND
来源
BRITISH JOURNAL OF UROLOGY | 1996年 / 78卷 / 03期
关键词
D O I
10.1046/j.1464-410X.1996.00085.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:337 / 344
页数:8
相关论文
共 53 条
[51]  
Watanabe R, 1994, Int J Urol, V1, P43, DOI 10.1111/j.1442-2042.1994.tb00007.x
[52]   WILD-TYPE P53 INDUCES APOPTOSIS OF MYELOID LEUKEMIC-CELLS THAT IS INHIBITED BY INTERLEUKIN-6 [J].
YONISHROUACH, E ;
RESNITZKY, D ;
LOTEM, J ;
SACHS, L ;
KIMCHI, A ;
OREN, M .
NATURE, 1991, 352 (6333) :345-347
[53]  
ZOU CP, 1994, CANCER RES, V54, P5479